![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » GILEAD TO ACQUIRE MYOGEN FOR $2.5 BILLION
GILEAD TO ACQUIRE MYOGEN FOR $2.5 BILLION
Gilead Sciences Inc., the world's third-biggest biotechnology company, said on Monday it agreed to acquire Myogen Inc. for $2.5 billion in a surprise transaction that gives Gilead access to Myogen's experimental hypertension drugs. MSN Money (http://news.moneycentral.msn.com/provider/providerarticle.asp?feed=OBR&Date=20061002&ID=6067386)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct